Cancer, Chemotherapy
Conditions
Brief summary
This study will investigate the ability of virtual reality to function as a novel distraction intervention and improve the experience of patients who are receiving chemotherapy in the infusion clinic.
Detailed description
Objectives: Primary Objective: \- To deploy and evaluate virtual reality as an intervention for stress, pain, and negative affect Secondary Objective: \- To evaluate cyber sickness and patient satisfaction related to the virtual reality treatment
Interventions
BEHAVIORALVirtual reality therapy
Participants will watch a video allowing them to view nature, dinosaurs, animals, and human interactions in three dimensions during a session lasting 11 minutes.
BEHAVIORALQuestionnaires
Questionnaires will be completed regarding stress, pain and affect
PROCEDUREMeasure heart rate
To be measured prior to starting treatment and halfway through the 11 minute Video
BEHAVIORALCyber sickness measurement
To be measured using the fast motion sickness scale
Sponsors
Cody Stansel
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* At or above the age of 18 * English Speaking * Diagnosed with cancer * No previous history of seizures, losses of awareness, or other symptoms linked to an epileptic condition * Not sensitive to motion sickness * Not currently experiencing any contagious conditions, infections, or diseases (particularly of the eyes, skin, or scalp) * Does not use a device to regulate heart rate or rhythm (such as a pacemaker) * Not taking antiarrhythmic medications * Not actively receiving radiopharmaceutical therapy Exclusion: * To ensure that there is sufficient time to complete the virtual reality treatment, patients who are scheduled for visits for periods of less than one hour will not be included in this study. Additionally, patients must consent to participating in the study on the day of the experience. * Patients who are asleep prior to consenting will not be asked to participate in the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Positive or negative effect of Virtual Reality therapy on improving the experience of participants receiving chemotherapy | Approximately 12 months | Measured by the Positive and Negative Affect Scale (0=minimum to 5=maximum). Consisting of a number of words that describe different feelings and emotions. Patients are instructed to indicate to what extent they currently feel each of the feelings or emotions. Afterwards, patient responses are scored to produce a numerical positive affect score and a negative affect score. |
| Measure the affect of Virtual Reality Therapy on improving stress | Approximately 12 months | Measured by stress level using the stress numerical rating |
| Measure the affect of Virtual Reality Therapy on improving pain | Approximately 12 months | Measured by pain level using the pain numerical score (scale 0 (none) to 10 (worst) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Rate of cyber sickness (Virtual Reality Therapy Arm Only) | Approximately 12 months | Measured with the Fast MS Scale (FMS), a verbal rating scale ranging from zero (no sickness at all) to 20 (frank sickness). |
Countries
United States
Outcome results
None listed